Originally published In Press as doi:10.1074/jbc.M109848200 on October 19, 2001
J. Biol. Chem., Vol. 277, Issue 7, 5290-5298, February 15, 2002
Unusual Binding Properties of the SH3 Domain of the Yeast
Actin-binding Protein Abp1
STRUCTURAL AND FUNCTIONAL ANALYSIS*
Barbara
Fazi
,
M. Jamie T. V.
Cope§¶
,
Alice
Douangamath¶**,
Silvia
Ferracuti
,
Katja
Schirwitz**,
Adriana
Zucconi
,
David G.
Drubin§,
Matthias
Wilmanns**,
Gianni
Cesareni
, and
Luisa
Castagnoli

From the
Department of Biology, University of Rome
Tor Vergata, Via della Ricerca Scientifica, 00133 Roma, Italy, the
§ Molecular and Cell Biology, 400 Barker Hall, University of
California, Berkeley, California 94720-3202, and
** EMBL/DESY-Hamburg, Geb 25A, Notkestrasse 85, D-22603
Hamburg, Germany
Received for publication, October 11, 2001
 |
ABSTRACT |
Abp1p is an actin-binding protein that
plays a central role in the organization of Saccharomyces
cerevisiae actin cytoskeleton. By a combination of two-hybrid and
phage-display approaches, we have identified six new ligands of the
Abp1-SH3 domain. None of these SH3-mediated novel interactions was
detected in recent all genome high throughput protein interaction
projects. Here we show that the SH3-mediated association of Abp1p with
the Ser/Thr kinases Prk1p and Ark1p is essential for their localization
to actin cortical patches. The Abp1-SH3 domain has a rather unusual
binding specificity, because its target peptides contain the
tetrapentapeptide
+XXXPXXPX+PXXL with positive charges flanking the polyproline core on both sides. Here
we present the structure of the Abp1-SH3 domain solved at 1.3-Å
resolution. The peptide-binding pockets in the SH3 domain are flanked
by two acidic residues that are uncommon at those positions in the SH3
domain family. We have shown by site-directed mutagenesis that one of
these negatively charged side chains may be the key determinant for the
preference for non-classical ligands.
 |
INTRODUCTION |
The actin cytoskeleton plays a key role in many essential cellular
processes, such as motility, endocytosis, secretion, and membrane
recycling (1-3). As a consequence, its organization and dynamic
rearrangements need to be tightly controlled spatially and temporally.
A thorough understanding of the interaction network connecting all the
actin-associated proteins, the scaffolds and the anchoring proteins, is
likely to help to clarify the mechanisms underlying its coordinated
regulation (4).
Most of the components of the yeast cell cytoskeleton have homologues
in mammals where they often play similar roles (5-7). Abp1p1 (actin-binding
protein) is a Saccharomyces cerevisiae protein homologue to
the mouse mAbp1p-SH3P7, which is a Src kinase target involved in
polarized cell growth and motility (8, 9). The yeast Abp1 protein is
592 amino acids long and includes an actin depolymerizing
factor-homology domain at the N terminus and a SH3 domain at the
C terminus of the protein (10). Abp1p is found concentrated in the
actin patches that are enriched at the sites of polarized cell surface
growth in the bud of budding yeast and in the mating projection of
mating yeast. The overexpression of Abp1p disturbs the actin
cytoskeleton and leads to an aberrant budding pattern and cortical
actin assembly (11). Deletion of the ABP1 gene, on
the other hand, does not cause any apparent cytoskeletal defect (12).
Abp1p, however, is found to be essential when any of the genes encoding
for Sac6p (the actin filament-bundling protein, fimbrin), Sla1p, Sla2p,
or Prk1p is deleted (13, 51). These proteins, which functionally
interact with Abp1p, are also localized in the cortical actin
cytoskeleton (11, 13). The observed negative synergism in yeast cells
carrying combinations of deletions in ABP1-SH3 and in the
SLA1, SLA2, and SAC6 genes suggests that these gene products perform redundant essential function(s) that require the presence of an intact Abp1p-SH3 domain. Moreover, this synthetic lethality is not rescued by Abp1p devoid of
its SH3 domain, suggesting a significant role for this protein interaction module (14).
To further characterize the role played by Abp1p, we have set out to
identify its binding partners. More specifically, we have explored the
role played by the SH3 domain in the assembly and regulation of these
actin structures. The SH3 family of protein-protein interaction domains
includes >1200 modules 60-70-amino acids long sharing an identity of
at least 30%. More than 1000 proteins containing SH3 domains are found
in many cell compartments and are involved in different functions
(e.g. cell cycle control, signal transduction, or
cytoskeleton organization). Typically, an SH3 domain recognizes and
binds to polyproline-rich regions, which adopt a type II left-handed helix conformation (15, 16). The SH3 peptide recognition surface includes an hydrophobic cleft that binds to the proline-rich core and
is flanked on one side by variable loops (RT and the N-Src loops) that contribute to the recognition specificity and determine ligand register and orientation (17, 18). A typical SH3 ligand contains
a PXXP motif that is hosted in the hydrophobic cleft. Depending on the presence of a positive charge at the N or C terminus, the peptides bind in either of the two possible orientations and are
classified as class 1 (RXXPXXP
consensus) or class 2 (PXXPXR consensus). Recently, the recognition repertoire of the SH3
domain family has been shown to be more diverse than originally thought including atypical ligands, which do not contain positively charged residues that are proline-independent or tyrosine-based (19-21).
In this study, we have determined the three-dimensional structure of
the Abp1p-SH3 domain, which accounts for its unusual recognition
specificity. Furthermore, we have identified as Abp1-SH3 partners
several proteins that were previously implicated in processes related
to endocytosis. For two of these Abp1-SH3 partners, the serine/threonine kinases Ark1p and Prk1p, we have proved that in
vivo Abp1p acts via its SH3 domain as an adaptor, which is essential for correct localization of the two kinases to cortical patches. Because Prk1p functions as a negative regulator of
endocytosis, our results suggest that Abp1p links the cortical actin
cytoskeleton to the control of endocytosis.
 |
EXPERIMENTAL PROCEDURES |
Yeast Two-Hybrid Assay--
The plasmids used as baits in
two-hybrid screenings were pyABP, AmpR, ColE1ORI, TRP1,
CEN6, and GAL4BD (aa 1-147) fused to ABP1-SH3 and pyABPm from pyABP, encoding the
Abp1-SH3-mutated in W569A. The SH3 domain (Pro-535-Asn-592) was
amplified from yeast DNA using the oligonucleotides R403
(AAAGCgaattcAAAATCCTTGGGCCACAG) inserting an EcoRI site and
R404 (GACGTgagctcCTAGTTGCCCAAAGACAC) inserting a SacI site.
The yeast genomic library was cloned into pACT, AmpR, ColE1 ORI,
LEU2, and GAL4AD (amino acids 768-881) fused to
yeast genomic DNA fragments [CLONTECH].The
selection was performed in Hf7c or in Y-190
[CLONTECH]. The
-galactosidase test in liquid
was performed after transformation into Y-187 according to the protocol
by the manufacturer (CLONTECH). The positive
control plasmids were from CLONTECH, such as pCL1
expressing GAL4 full-length, pVA3-1 expressing GAL4BD (amino acids 1-147) fused to murine p53 (amino
acids 72-390), and pTD1-1 expressing GAL4AD (amino
acids 768-881) fused to SV40 large T antigen (amino acids 87-708).
All prey plasmids were found to be negative when tested with pLAM5
expressing GAL4BD fused to human lamin C protein. The
positive interactors in Fig. 1 showed a
-galactosidase
activity that is 100-400 times higher than that of the negative
control (0.003 units).
Plasmid pyArc40 was used for the test with Arc40p from pACT2 and
ARC40 inserted into BamHI-XhoI, which
was fused to GAL4AD using the oligonucleotides R804,
AATTTggatccCATGTCATTTTCCAATTCTAAAGAC, and R805, AATTTaagcttTTAAATTGTATAAATGACGATCTTA.
The yeast strains used were HF7c (MATa ura3-52 his3-200
ade2-101 lys2-801 trp1-901 leu2-3112 gal4-542 gal80-538
LYS2::GAL1UAS-GAL1TATA-HIS3, URA3::GAL417-mers(x3)-CYC1TATA
Lacz
(CLONTECH)), Y190 (MAT
his3-200 ade2-101
trp1-901 leu2-3 112 gal4
gal80
cyhr2
LYS::GAL1UAS-HIS3TATA-HIS3,
URA3::GAL1UAS-GAL1TATA-lacz (CLONTECH)), and Y187 (MAT
his3-200
ade2-101 trp1-901 leu2-3 112 gal4
met- gal80
URA3::
GAL1UAS-GAL1TATA-lacz (CLONTECH)).
Affinity Selection of a Yeast Genomic Library Displayed on Phage
Capsid--
Fragments (50-1000 bp) of yeast DNA obtained by random
priming with partially degenerated oligonucleotides were cloned into the phagemid vector Pc89 between the EcoRI and
BamHI sites at the 5' end of M13 gene
VIII, which encodes the major coat protein (22). The library
that we obtained (108 independent clones representing >50
times of the whole genome) was a collection of recombinant phage
particles displaying yeast protein fragments of which average length
was 40 amino acids. These particles were affinity-selected for their
ability to bind to the full-length yeast Abp1 protein expressed as a
GST fusion and linked to glutathione S-Sepharose.
10 µg of GST-Abp1p were incubated for 1 h at 4 °C with
1010 recombinant filamentous phage particles displaying
yeast protein fragments. Unbound phages were discarded by washing the
resin with 1× Tris-buffered saline containing 0.1% Tween 20. Affinity-selected clones were amplified in a bacterial host DH5
and
subjected to a new affinity selection cycle. After the third cycle,
selected clones were tested by ELISA for their capability of
interacting with GST-Abp1p, and the sequence of the yeast DNA fragments
were determined by automatic sequencing of phage single-stranded DNA using universal primer
40. The Abp1-SH3 fusion to GST was in PYEX(ABP1-SH3), a pGEX2T derivative in which the SH3 domain
(Pro-535-Asn-592) was inserted into EcoRI-SacI,
with oligonucleotides R403 and R404. The oligonucleotides R649
(TATATggatccATGGCTTTGGAACCTATT) and R650
(TCTGTgaattcGTTGCCCAAAGACACATA) were used to insert the ABP1 gene cloned into pGEX6P-1 (EcoRI-BamHI) to
determine the synthesis of the bait protein Abp1p as a GST fusion. The
GST-Abp1p fusion protein produced in the bacterial strain HB101 was
immobilized on a glutathione-Sepharose resin. The bacterial strains
used were DH5
(F'::supE44
(lacZYA-argFV169) deoR endA1 gyrA96 hsdR17
(r
mk+) recA1 relA1) and HB101
(supE44 hsdS20 (r-B m-B) recA13 ara-14 proA2 lacY1 galK2 rplS20
xil-5 mtl-1 leuB).
Panning of Phage-displayed Peptide Libraries--
Phage panning
is performed as described previously (23-26). A nonapeptide repertoire
of random sequence exposed on the pVIII coat protein of the filamentous
phage M13 (1010 particles) were challenged with
10 µg of the purified GST-SH3 domain of Abp1p. After three rounds of
affinity selection (8 h at room temperature in 1-2 ml of PBS), washing
(10 ml of PBS + 0.005% Tween 20), elution (10 min at room temperature
in 100 µl of 0.1 M HCl, pH 2.2), and neutralization (10 µl of Tris-HCl 2 M, pH 9.0), the specifically
bound phages were recovered by infection. The single-stranded DNAs of
the affinity-selected phage were sequenced to determine the sequence of
the selected peptides.
Pull Down Assay from Yeast Cell Extract--
The yeast extracts
were prepared from the kinase null strains as follows. The prk1 null
strain DDY1558 was transformed with the following plasmids: pDD558 from
pRS316, CEN, URA3, 6Myc-PRK1 (13) expressing 6Myc-Prk1p under its own
promoter; pDD561 from pTS408, GFP-PRK1-kinase-dead K56A, Gal promoter,
CEN, URA3 (13) expressing a GFP-tagged Prk1p under GAL
promoter; and pDD961 from GFP-PRK1-kinase-dead K56A in which the
P752PPK755 of Prk1p was mutated into alanines. The ark1 null
strain DDY2115 was transformed with the following plasmids: pDD382 from
pRS315, CEN, LEU2, ARK1-6Myc (13) expressing a
Ark1p-6Myc under its own promoter and pDD962 from pRS315, CEN,
LEU2, ARK1-6Myc kinase-dead K56A in which the sequence Lys-608-Pro-626 of Ark1p-6Myc was substituted by two alanines.
To perform the pull down experiment using mutations in the SH3 targets,
the ark1 null strain was transformed with pDD962 expressing the
Ark1p-6Myc devoid of its polyproline tail, otherwise cells were
transformed with pDD961 encoding the GFP-Prk1p with a mutagenized
proline stretch. pDD961 and pDD962 were both created using a PCR-stitch
technique as follows. To make pDD961, two first-round of PCR reactions
were performed using pDD554 (13) as template with primer pairs 1) AF19
and JC74 and 2) JC95w and JC75. The products from these reactions were
pooled and amplified in a second round using AF19 and JC95w. pDD561 was
digested with AflII and XbaI, and the removed
fragment was replaced by similarly cut product from PCR round 2. A
similar procedure was used to make pDD962 using pDD1160 (13) as
template: SY47 and JC77 and JC76 and SY51 in the first round, SY47 and
SY51 in the second round, and replacing an NcoI fragment in
pDD1160. All mutations were verified by sequencing.
As a bait for the pull down assay, the Abp1p-SH3 domain
(Pro-535-Asn-592) in PYEX(ABP1-SH3) was expressed in Escherichia
coli HB101 and purified as a fusion to GST. When using the mutated bait, pYEX(ABP1-SH3 W569A) was used. The conserved tryptophan 569 in
the SH3 peptide-binding pocket was changed into alanine using the
oligonucleotide R591 (TAGTTCCCCTAGCCACGCGTCATCGTCGACAAA). The
GST-fused bait proteins were immobilized on glutathione
S-Sepharose (Amersham Biosciences, Inc.) (30 µg) and
incubated at 4 °C for 2 h with the concentrated extract (10 mg/ml) equivalent to 100 ml of cells at A600 = 0.5. After extensive washing, the pellet is suspended in SDS and
run on PAGE. The bands visible after immunoblotting with anti-Myc or
anti-GFP antibodies were obtained loading the input extract from 10exp8
cells or the pulled down materials from 10exp9 cells. The Myc-tagged
proteins were detected using the anti-Myc antibody (Invitrogen), The
GFP-tagged proteins were detected using the anti-GFP antibody
(Invitrogen). PYEX was a derivative of pGEX2TK with an expanded
multiple cloning site. The yeast strains used in this study were
DDY1558 (MATa prk1
::LEU2 his3-200
ura3-52 leu2-3,112 lys2-801 (Drubin laboratory)) and DDY2115
(MATa leu2 trp1 ura3-52 prb1-1122 pep4-3 pre1-451
ark1
::URA3 (Drubin laboratory)). Primers
used were AF19 (ATACTAGTTAAAGAGTTCTGATGATC), JC74
(GGTAAAGATAAATCAAGACCACCACGTGCAGCAGCTGCACCACTACATTTAAGGACAGAAATTC), JC95w (GCTCTAGATTAAACTTTGCTGGGAAACC), JC75
(GAATTTCTGTCCTTAAATGTAGTGGTGCAGCTGCTGCACGTGGTGGTCTTGATTTATCTTTACC), SY47 (GATCTTGCCATATTAAGCGG), JC77
(GGATAACTTTCGTCCCGCGAGGAGCAGAGCAGCTGTTTTTTTGTCTTTTGAAATCGGGCC), JC76
(GGCCCGATTTCAAAAGACAAAAAAACAGCTGCTCTGCTCCTCGCGGGACGAAAGTTATCC), and
SY51 (CGGAGCTCGGCAACCTTCATGCCTTATGC).
ELISA--
Affinity selections with polyproline peptides were
performed in microtiter plates (Nunc) coated overnight at 4 °C with
5 µg/ml of streptavidin (Sigma) in 100 µl of PBS (10 mM
Na2HPO4/KH2PO4, pH 7.2, 150 mM NaCl). The coated plates were washed 10 times with PBS and 0.05% Tween 20 and incubated for 30 min at 25 °C with biotinylated peptides (10 µM in PBS). Plates were washed
again and blocked for 1 h at 25 °C with 4% bovine serum
albumin in PBS. The GST-SH3 fusion proteins were added (1 µg). After
10 washes, anti-GST serum in goat (Amersham Biosciences, Inc.) was
added in bovine serum albumin and 4% PBS for 1 h at room
temperature followed by incubation with anti-goat
alkaline-phosphatase-conjugated antibody (Sigma). The ELISA-utilizing
phage-exposed peptides were performed using 10exp9 phage
particles/well.
Co-localization--
Abp1 null cells, DDY322, were
co-transformed either with pDD561 encoding GFP-Prk1p (kinase-dead
version) or with pDD562 encoding GFP-Ark1p (kinase-dead version)
together with one of the following Abp1p expression vectors: pDD187
from pRS315, CEN, ABP1 full-length, AmpR, LEU2, HIS3; pDD188 from
Abp1p-SH3 deleted (12); and pyABPSH3mut from pDD189 in which the
ABP1-SH3, mutated in W569A, is inserted into
SphI-NcoI site with oligonucleotides
AAATccatggGCCACAGC and ACTTAgcatgcCTAGTTGCC. The expression of the
GFP-tagged proteins was induced from a GAL1-10 promoter as in Cope
et al. (13). Cells were visualized 16 h after transfer
from medium containing glucose to that containing galactose as a carbon
source. When using the polyproline-mutated version of Prk1p, DDY130
cells were transformed with pDD961 encoding kinase-dead Prk1p with
proline residues 752-755 changed into alanines under the Gal promoter. The yeast strains used in this study were DDY322 (MAT
abp1::LEU2 his3
200 ura3-52 leu2,3112
(Drubin laboratory)) and DDY130 (MATa his3
200 ura3-52
leu2-3,112 lys2-801 Parental wild type strain (Drubin laboratory)).
Crystallization and Data Collection--
The SH3 domain
(Pro-535-Asn-592) of Abp1p was cloned into the pRSETA
(NdeI/HindIII) Invitrogen expression vector using
the oligonucleotides R553 and R508. The protein was expressed in
Bl21pLysS (Promega) induced with 0.5 mM
isopropyl-1-thio-
-D-galactopyranoside for 4 h at
37 °C. Cells were collected and sonicated 10 times for 10 s in
50 mM Tris-Hcl, pH 8.0, 20 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol. After
centrifugation at 45,000 rpm to remove cell debris, the supernatant was
loaded onto Q-Sepharose high performance column (XK 26/20). The protein
was concentrated with 80% ammonium sulfate, spun in a vivaspin
concentratop (10,000 MWCO) (Sartorius), and further purified on
Hiload XK 16/60 Superdex 75 (size exclusion). The peak fractions were
concentrated to 10 mg/ml and used for crystallization.
Abp1-SH3 domain was crystallized by the sitting-drop technique using
3.2 M ammonium sulfate in 100 mM
bis-Tris-propane at pH 8.0 as a precipitating agent and 12 mg/ml
Abp1-SH3 domain in the purification buffer. The crystals were optimized
by seeding techniques and reducing the protein concentration to 1.2 mg/ml.
X-ray data were collected at 100K at the Beamline BW7B
(EMBL/DESY, Hamburg) using a 345-MAR research image plate as
detector. The high concentration of ammonium sulfate was sufficient to
cryoprotect the crystal. The data were processed with the Denzo and
Scalepack package (27). The crystal belongs to the
P212121 space group with unit-cell
parameters a = 24.0 Å, b = 38.1 Å,
and c = 59.1 Å. The Wilson plot, calculated in the
resolution range of 3.9-1.3 Å using the program TRUNCATE from the
CCP4 package (28) yielded an overall isotropic temperature factor of
9.8 Å2. The statistics of the data processing are reported
in Table I.
View this table:
[in this window]
[in a new window]
|
Table I
Data-processing statistics of Abp1 SH3 domain
Numbers in parentheses indicate the values in the highest resolution
range (1.32-1.30 Å).
|
|
Structure Solution and Refinement--
The structure was phased
by molecular replacement with AMoRe (29) using the 1.5-Å resolution
structure of c-Crk SH3 domain (PDB entry code 1CKA), 35% sequence
homology, and 20% sequence identity (16) as a search model. The
observed data between 15 and 3.5 Å resolution were used employing an
integration sphere of 12 Å. The final solution had a correlation
coefficient of 32.7 and a R-factor of 51.9%.
The structure was built using an ARPwARP package (30) and
refined using REFMAC5 (31). The refinement program used the data from
15 to 1.3 Å. The data set contained 13,742 unique reflections from
which 687 were excluded for the calculation of the
Rfree (32). One molecule of 58 residues (497 non-hydrogen protein atoms) is present in the asymmetric unit.
Anisotropic refinement of the individual atoms was applied, which
further improved the statistics.
The weighted 3Fo
2Fc electron
density map displayed 11 residues in double conformations. The solvent
molecules presenting reasonable hydrogen bonds (2.3-3.3
Å) were added using the option Arp solvent from the ARPwARP package.
Two large tetrahedral-like electron density peaks were interpreted as
sulfate ions from the crystallization conditions. Finally, the
structure was validated by the program PROCHECK (33). A summary of the
refinement statistics is given in Table
II.
 |
RESULTS |
Identification of Ligands of the SH3 Domain of Abp1p--
The
yeast two-hybrid approach is the most popular selective method to
search for protein partners. However, we have recently demonstrated the
feasibility of achieving similar goals by panning phage-displayed
libraries in which cDNA or genomic fragments are fused to phage
capsid genes (34). We have observed that the two methods are partly
complementary, and that a search carried out with a specific bait
domain by both methods results in a better coverage of the ensemble of
potential partners (35).
By applying such a combined approach to the SH3 domain of Abp1, we have
identified seven prey proteins, which were selected by either method
(Table III). Our results confirm that the
Abp1-SH3 binds to the adenylyl cyclase-associated protein Srv2 (12). In
addition, our two-hybrid screen also identifies the open reading frame
product Yir003wp, the unconventional myosin Myo5p, and the kinase Prk1p
as putative partners of Abp1p. Using the entire Abp1p as a bait, we
have also screened a yeast genomic library displayed on filamentous
phage capsids obtained by fusing random fragments of the yeast genome
to the 5' end of f1 gene VIII. This approach permitted us to
identify a second Ser/Thr kinase, Ark1p, as an Abp1-SH3 ligand. The 247 amino acid N-terminal catalytic domain of Ark1p is 73% similar to the
catalytic domain of Prk1p. The two kinases aside from a similar
C-terminal proline-rich sequence are otherwise rather divergent (13).
The Ark1p peptide region selected by phage display corresponds to amino
acids Arg-561-Leu-627 (Fig. 1) in which
two putative SH3-binding motifs are present. Because the fragment of
Ark1p was selected by panning phage-displayed libraries, we can exclude
the possibility that the interaction between the Ark1p kinase and the
SH3 domain is bridged by a third protein.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 1.
Selection of protein partners and recognition
specificity of the Abp1-SH3 domain. A, a
repertoire of nonapeptides of random sequence (22) and a biased
pentadecapetide library (37) were panned for three consecutive cycles
with a GST-Abp1-SH3 domain bound to gluthathione-Sepharose. The
sequence of the peptides displayed by the selected ligands were deduced
from the DNA sequence of the hybrid capsid genes, and from the
alignment, an extended consensus was deduced. B,
inferred Abp1-SH3 target peptides obtained by comparison of the
sequence of the Abp1-SH3 protein partners with the phage-displayed
consensus.
|
|
Another putative partner of Abp1p-SH3 discovered by phage display is
Inp52p/Sjl2p, which is similar to synaptojanin, a mammalian synaptic
inositol 5-phosphatase that is suggested to have a role in the
regulation of membrane trafficking and actin cytoskeleton organization
(36). In the short yeast synaptojanin region selected as Abp1-SH3
ligand, we identify a putative SH3-binding motif
1115PPVVKKP1121. Finally, a protein of
unknown function, Ynl094wp, was repeatedly found by screening phage
display genomic libraries. The shorter selected region comprises the
residues from 471 to 504.
Identification of the Abp1-SH3 Consensus Target Motif--
The
Abp1p-SH3 targets selected by the two-hybrid approach contain several
proline-rich regions. However, sequence alignment does not permit the
definition of a clear consensus peptide ligand. In
preliminary experiments, we had already shown that the SH3 domain of
Abp1p does not bind to any of the typical SH3 ligands that we had
characterized in our laboratory.
To be able to identify in each protein the peptide that is bound by the
Abp1p-SH3 domain, we characterized its recognition specificity by
panning peptide libraries of random sequence displayed on filamentous
phage. We have initially selected peptides from a repertoire of
nonapeptides displayed by fusion to the major coat protein pVIII. After
three selection cycles, four clones, which were found to be positive in
ELISA, were characterized, and the amino acid sequence of the displayed
peptide ligands was deduced from the DNA sequence of the hybrid coat
gene (Fig. 1A). However, compared with other SH3 selections
carried out in our laboratory, fewer clones were selected, and they
were found to bind to the bait Abp1-SH3 less tightly (optical density
of 0.2-0.4 in ELISA, whereas typical SH3 showed an optical density of
>1.4 when tested with their partner peptides in similar experimental conditions). This result indicates that the SH3 domain of Abp1p has a
higher specificity, and that for tight binding, it requires a larger
number of specific residues in fixed positions and possibly a longer
peptide. The consensus sequence of the selected peptides, RPXPXXPXK, could be interpreted either
as an extended class 2 peptide, containing an extra positively charged
residue at the amino side, or an extended class 1 peptide, containing
an extra positively charged residue at the C terminus.
Because this first panning experiment did not yield a sufficient number
of ligand sequences, we have also panned a second library of
pentadecapeptides containing a fixed PXXP motif displayed at
a lower density by the filamentous phage pIII receptor protein (37).
The three selected pentadecapeptides reveal a slightly different
consensus, PXXPXRPXW#
(where # represents a hydrophobic residue), that can be interpreted as
an extended class 2 with a requirement for a proline after the
conserved positively charged and hydrophobic residues at the C terminus.
We used the consensus sequences obtained by the two panning
experiments to identify the best matches on the selected protein partners. Whenever visual inspection was not sufficient, we used a
position-specific profile derived from the phage display experiments as
described by Tong et al. (35). The results are illustrated in Fig. 1B. Although no protein partner contains an exact
match of either consensus, the predicted peptides identify a
third consensus, +XXPXXPX+PXX#, that can be
interpreted as a merge of the two phage-displayed consensus.
Ark1p, Prk1p, Srv2p, Inp52p, and Yir003wp contain a peptide that
matches most of the extended consensus. Myo5p and Ynl094p contain a peptide in which the conserved KP motif is preceded by a long
stretch of prolines.
Mapping of the SH3 Target Peptides on Prk1p and Ark1p--
To
verify by an independent method the physical interaction between the
SH3 domain of Abp1p and the Prk1p kinase, we have used Abp1-SH3 fused
to glutathione S-transferase to pull down Prk1p fused to an
N-terminal 6Myc-tag expressed in prk1 null yeast cell. As
shown in Fig. 2A, ~5%
6Myc-tagged Prk1 protein is pulled down by the Abp1p-SH3 domain. By
contrast, most of the binding is abolished when the conserved
tryptophan in the SH3 domain (Trp-569) is changed to an alanine.
Several bands can be identified with an anti-Myc-tag antibody in yeast
extracts expressing the Myc-tagged Prk1 protein, suggesting that this
protein is degraded either in vivo or during the preparation
of the protein extracts. However, only the full-length protein is
pulled down by the SH3 domain of Abp1p. This is consistent with our
identification of the SH3-binding site with the proline-rich region at
the C terminus of the Prk1 protein.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Affinity purification. The prk1 null
strain (A) and the ark1 null strain (B) were
transformed with pDD558 expressing 6Myc-Prk1p and pDD382 expressing
Ark1p-6Myc, respectively. Both kinases were expressed under the control
of their native promoters. The bait used for affinity selections are
GST alone, GST fused to the Abp1-SH3 domain, GST fused to the Abp1-SH3
mutated in a conserved tryptophan (W569A), and GST fused to the Abp1p
full-length as indicated above each lane. The faster
migration of the band corresponding to Ark1p in the GST-Abp1p
lane in B is caused by the co-migration of the
bait protein as verified by Ponceau staining. C, extracts
from prk1 (a and b) or ark1 (c and
d) null strains transformed with plasmids expressing
GFP-Prk1p (Extract a),
GFP-Prk1p-polyproline-mutated (Extract b),
Ark1p-6Myc (Extract c), and
Ark1p-polyproline-deleted-6Myc (Extract d). These
extracts are affinity-selected over immobilized GST or GST fused to
Abp1p or Abp1-SH3 proteins as indicated above each lane.
SDS-PAGE is followed by immunoblotting with anti-Myc or anti-GFP. The
input extract is from 10exp8 cells, and the pulled down extract is from
10exp9 cells incubated with 20 µg of bait proteins.
|
|
Similarly, we confirmed by a pull down experiment the interaction
between Abp1p and the Ark1p tagged with 6Myc at the C terminus (Fig.
2B). The Ark1p-6Myc was efficiently pulled down by
GST-Abp1-SH3. By contrast, Abp1-SH3 (W569A) mutated in the conserved
tryptophan does not bind to Ark1p. Furthermore, the SH3 domain seems to
be as efficient as the full-length Abp1p protein in the pull down assay. These results further stress the primary role of the SH3 domain
of the scaffold protein Abp1p in binding to the two regulatory kinases.
Moreover, we have used the pull down assay to confirm that the peptides
identified by matching the phage display consensus to the
Ark1p and Prk1p protein sequences indeed mediate the interaction with
the SH3 domain. To this end, we have modified the two kinase genes by
altering the sequences encoding the putative SH3-interacting motifs. As
a result, four residues in the polyproline stretch (752PPPK755) at the C terminus of GFP-Prk1p
were changed into alanines, and the 19 residues
(608KPTPPPKPSHLKPKPPPKP626) in the C-terminal
region of Ark1p-6Myc were deleted and substituted with two alanines.
The two kinases, altered in their putative SH3-binding motifs, no
longer bind to the Abp1-SH3 as judged by the pull down experiments
(Fig. 2C).
Interaction of the SH3 Domain of Abp1p with the C-terminal
Proline-rich Peptide of Prk1p and Ark1p Is Essential for Localization
of the Kinases to Actin Cortical Patches--
Cope et al.
(13) have shown that the localization to the actin cortical patches of
Prk1p and Ark1p is dependent on Abp1p. To verify whether the in
vivo co-localization of Abp1p with both Prk1p and Ark1p is
mediated by the direct physical interaction that we have identified
in vitro, we looked at the localization of GFP-tagged
kinases in abp1 null yeast cells expressing different derivatives of the Abp1 protein. In this experiment, we used both kinases carrying an inactivating mutation in their enzymatic domain (kinase-dead), because elevated levels of either Ark1p or Prk1p result
in abnormal cell morphology and ultimately in cell death (13). Each of
these two strains was further transfected with one of three different
plasmids expressing (i) a wild type Abp1p, (ii) an Abp1p-deleted of the
SH3 domain, or (iii) an Abp1p with a mutated (W569A) SH3 domain. Normal
cortical spots of kinase localization are visible only in cells that
are transfected with a plasmid expressing the wild type Abp1p,
demonstrating that the SH3 domain is essential for proper localization
of the two GFP-tagged kinases (Fig. 3,
upper panel). However, we did notice a residual cortical
localization of Prk1p even in the absence of Abp1p, whereas Ark1p was
completely delocalized.

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 3.
Localization of Prk1p to actin cortical
patches depends on an intact polyproline motif at its C
terminus. Yeast cells were transfected with plasmids
directing the synthesis of GFP-Prk1p (upper panel, PRK1) or
GFP-Prk1p carrying a mutation in the polyproline stretch (lower
panel, PRK1 mut poly P). In the panels on
the left, the clear spots are attributed to
fluorescence of the GFP-Prk1p hybrid protein. Actin was visualized in
the two panels on the right by staining with
rhodamine-conjugated phalloidin (Rh). To avoid disturbing
cell physiology by overexpressing the Prk1p kinase, a mutationally
inactivated kinase was used in this experiment (GFP-Prk1p K56A).
|
|
To further characterize the SH3 interaction in vivo, we
examined the localization of a GFP-tagged Prk1p kinase that was altered in its Abp1-SH3-binding motif in the C-terminal region. The cells were
transformed with a plasmid encoding a GFP-PRK1 gene fusion in which the
four residues (752PPPK755) had been changed
into alanines. As a result, the Prk1p mutated at the polyproline site
is no longer localized to the cortical patches (Fig. 3, lower
panel). These results identify the SH3 domain of Abp1p and the
polyproline motifs of Prk1p and Ark1p as essential regions for the
proper cellular localization of both kinases to the cortical actin patches.
Three-dimensional Structure of the Abp1-SH3 Domain--
The
interaction of a standard SH3 ligand and its receptor domain can be
schematically split into two contributions. The first is rather
nonspecific and derives from PXXP contacting the two hydrophobic pockets, while the second derives from further often electrostatic interactions in the so-called specificity pocket. As
outlined above, the SH3 domain of Abp1p displays a peculiar recognition
specificity, and differently from most SH3 domains described so far, it
does not bind tightly to any short class 1 or class 2 peptide that we
have tested. Abp1-SH3 ligands are characterized by two positive side
chains separated by seven of eight residues containing a
PXXP motif. To understand the structural basis of this novel
specificity, we have determined the three-dimensional structure of the
Abp1-SH3 domain at 1.3-Å resolution. The high resolution provides a
detailed model in which double conformations and numerous solvent
molecules could be determined accurately (Fig.
4A). The overall structure is
similar to other SH3 domains consisting of a compact
-barrel of five
anti-parallel
-strands forming two orthogonal
-sheets (Fig.
4B). At first sight, the SH3-binding pockets, which normally
host the PXXP-binding motif, do not reveal any peculiar
characteristics that would readily explain the unusual binding
properties of Abp1p. The residues that normally flank the hydrophobic
cavities can be superimposed to the equivalent residues of the Abl and
Src SH3 domains for instance (Fig.
5).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 4.
Three-dimensional structure of the SH3 domain
of Abp1. A, electron density. A
weighted 3Fo 2Fc electron
density map at 1 -level around residue Pro-50 (P-50).
B, ribbon representation of Abp1-SH3. The residues
composing the PXXP-binding site are represented in
yellow. Residues Glu-6 (E16) and Glu-21
(E21) that have been modified by site-directed mutagenesis
are indicated in red. Y53, Tyr-53; Y9,
Tyr-9; W35, Trp-35; N52, Asn-52; Y7,
Tyr-7; E6, Glu-6.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 5.
Superposition of the Abp1p-SH3 domain
(red) with Sem5-SH3 (green) and
c-Abl-SH3 (blue). The residues in the
Abp1-SH3-PXXP-binding site are labeled. They overlap almost
perfectly to those in Sem5-SH3 and c-Abl-SH3. The figure was produced
using MOLSCRIPT (49). Y53, Tyr-53; Y9, Tyr-9;
W35, Trp-35; N52, Asn-52; Y7, Tyr-7;
P50, Pro-50.
|
|
By considering the multiple alignment of the SH3 domains of known
specificity and by concentrating on the residues that in the
three-dimensional structure flank the ligand-binding pocket, the most
striking peculiarity observed in Abp1-SH3 is Glu-6 that precedes the
conserved tyrosine at position 7. The vast majority of SH3 domains have
a hydrophobic residue at the Glu-6 position. Although this side chain
is not in direct contact with the ligand in the SH3-peptide complexes
of known structure, it is possible that the presence of a negative
charge in an otherwise hydrophobic surface results in a decrease of the
affinity for a "typical" PXXP peptide. Possibly because
of the suboptimal interaction with the PXXP motif, the
Abp1-SH3 physiological partners extend their contacts beyond the first
hydrophobic pocket that is normally boxed by the aromatic ring of
Tyr-7. Notably, just beyond the Tyr-7 side chain, the surface of
Abp1-SH3 displays a second glutamate residue (Glu-21) in a position
that in most SH3 domains is occupied by a positively charged residue.
Because until now we have been not successful in our attempts to
co-crystallize the Abp1-SH3 domain with its target peptides, we have
designed site-directed mutants to test this model. In one mutant, Glu-6
was changed into Leu as found in most SH3 domains, and in a second one,
Glu-21 was substituted by Lys.
When these mutant domains were assayed in pull down experiments, they
proved to be at least as efficient as wild type in binding to Prk1p
(data not shown). This result proves that neither of the residues
tested plays a major role in ligand binding. However, consistent with
the model, the mutant G6L has acquired the ability to bind to a
classical (class 1) peptide,
LSSRPLPTLPSP, thus pointing to the
important role of the side chain at the position corresponding to Glu-6
in shaping the typical SH3-binding pocket (Fig.
6C).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 6.
Charge potential surface representation.
A, Abp1p-SH3 domain. B, Sem5-SH3 domain. The
color code from blue to red
corresponds to the charge potential at the surface of the molecule from
positive to negative, respectively. Compared with the charge
distribution of Sem5-SH3, Abp1p-SH3 presents an additional negatively
charged patch in the region opposite to the specificity pocket. The
figure was produced using GRASP (50). C, ELISA. Two
biotinilated peptides (10 µM) were adsorbed to a
microtiter well coated with 5 µg/ml of streptavidin. 0.3 µg of the
wild type SH3 domain or of its mutated form fused to GST was soaked in
the well, and domain binding was monitored by probing with polyclonal
anti-GST goat serum and with anti-goat alkaline-phosphatase-conjugated
antibody. The amino acid sequences of the peptides used in the assay
are reported at the right of the histogram. The GST fusions
of the Abl and SH3 domains are used as controls.
|
|
 |
DISCUSSION |
The large scale two-hybrid screening experiments have failed to
confirm the characterized interactions of Abp1p with Rvs167p and Srv2p
(11, 12, 38) and have revealed a new putative partner of Abp1p,
Yor284wp (39, 40). However Yor284wp does not contain proline-rich
regions that are typical signatures for SH3 domain targets.
In this study, by combining yeast two-hybrid screenings and selections
of protein fragments displayed on filamentous phage capsids, we have
identified six new ligands of the Abp1-SH3 domain that are potentially
physiologically relevant. These include the two Ser/Thr kinases, Ark1p
and Prk1p. By mutating either a conserved tryptophan on the
Abp1-SH3-binding surface or the polyproline target peptides near the C
termini of the two kinases, we have shown that this SH3-mediated
interaction is responsible for the proper localization of both kinases
to actin cortical patches.
Prk1p was suggested to be a negative regulator of endocytosis by
several lines of evidence. In vivo, a loss of Prk1p activity suppresses the effects of a loss of function mutation in Pan1p, the
yeast homologue of Eps15. By phosphorylating Pan1p on threonine residues, Prk1p hinders the interaction of Pan1p with the endocytosis protein, End3p (41). The formation of the heterotrimeric complex Sla1p-End3p-Pan1p is required for proper cortical actin
organization and endocytosis (2, 42).
In our two-hybrid screen using Abp1-SH3 as a bait, we also selected the
unconventional (type I) myosin Myo5p and the product of an open reading
frame of uncharacterized function, Yir003wp. The interaction with Myo5p
has the potential to occur in vivo, because this motor
protein co-localizes with Abp1p in cortical patches. Another protein
that is implicated in endocytosis, the yeast synaptojanin Inp52p/Sjl2p,
was also found to bind to Abp1p-SH3 in our screenings. The interaction
we have characterized between Abp1p and Inp52p provides a possible
mechanism for the localization of Inp52p to actin patches following
hyperhosmotic stress (43). Finally the panning of phage-displayed
genomic libraries has identified the product of the reading frame
Ynl094wp as a partner of Abp1p. Collectively, the newly discovered
Abp1p ligands together with the information already available on their
function suggest a large web of SH3-mediated interactions that regulate
the dynamic assembly of actin and link it to the endocytic process.
Abp1p contains three acidic repeats containing the conserved DDW motif
that was shown to mediate the association of cortactin, WASP,
and Myo3p to the Arp2·Arp3 complex (44, 45). One of these motifs is
solvent-exposed in the N-Src loop of the SH3 domain. However, our
selection experiments have not revealed any Abp1-SH3 ligand that is a
component of the Arp2·Arp3 complex. Furthermore the full-length
protein Arc40p, a component of the Arp2·Arp3 complex that binds the
acidic motif at the tail of the Myo3p (44), could not bind to Abp1-SH3
in a two-hybrid assay or in an in vitro assay with purified
proteins (data not shown). Recently, the two other acidic regions of
Abp1p have been proven to be essential for Arp2·Arp3-binding and
actin polymerization (46).
These data emphasize the role of the yeast Abp1p as an
F-actin-associated link between protein complexes involved in actin polymerization and a number of proteins implicated during
endocytosis. Moreover, Abp1p can recruit to the actin patches
of regulatory kinases, which have an inhibiting role on endocytic
proteins. By phosphorylating their targets, Abp1p-associated Prk1p and
Ark1p may cause a disruption of the endocytic machinery and allow
vesicles to pinch off from the membrane and be transported away by
actin polymerization. Abp1p in this manner could be coordinating the membrane fission and actin-promoted movement. Fig.
7 illustrates the protein network
centered on the Abp1 protein.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Overview of the interaction web centered on
the actin-binding protein Abp1p. A, the Abp1-SH3
interactions with Myo5p and synaptojanin are inferred from yeast
two-hybrid and phage-display experiments, respectively, but have not
been yet confirmed in vivo. The interaction of the Myo5p
acidic tail with the Arp complex is from Evangelista et al.
(44). B, the interactions with the kinases Ark1p and Prk1p
are characterized in this work. The Abp1p interaction with the Arp
complex is deduced from sequence analysis and characterized in Goode
et al. (46). C, the Abp1p interactions with Srv2p
and with Rvs167p are from Lila and Drubin (12). Proteins are not drawn
to scale.
|
|
Several proteins involved in endocytosis and cytoskeleton dynamics
contain an SH3 domain (47). Recently, a number of reports have shown
that the binding potential of the SH3 domain family cannot be
restricted to peptides containing the PXXP signature (19-21). The comparison of the sequences selected by Abp1-SH3 from two
different phage-displayed peptide libraries reveals two
consensus sequences,
+PX(P/V/L)XXPX+ or
PXXPXRPXW(L/I). This
divergence might reflect the differences in peptide length and peptide
density in the two phage-displayed repertoires as well as the bias of the fixed PXXP sequence in the pentadecapeptide library.
However, by combining the two consensus sequences, we were
able to identify, on the sequence of the seven Abp1-SH3 protein
partners, peptides that conform to an extended consensus.
Most of the natural ligands of the Abp1-SH3 domain contain a peptide
that can be aligned to the consensus
+XXXPXXPXKPXXL (Fig. 1). In
the case of Prk1p and Ark1p, we have experimentally proved that this
motif indeed mediates the formation of the protein complex in
vivo. This motif can be interpreted as a modified class 2 motif
with N- and C-terminal extensions containing a positively charged and a
hydrophobic side chain, respectively. The Myo5p and the Ynl094wp target
peptides do not conform to this consensus but maintain the
conserved KP dipeptide preceded by a long stretch of prolines. The SH3
domain family is one of the most numerous classes of protein
recognition modules with more than 1000 different domains found in
protein data bases. Collectively, these domains play an important role in the formation of the protein networks, which control a number of
important cell functions. The ability to predict the preferred peptide
ligand of any SH3 domain and consequently infer its physiological targets would represent a substantial step forward in our attempt to
decipher the protein interaction network inside a cell directly from
genomic data. Although some predictive algorithms have been proposed,
they often fail when they are queried with domains that do not bind to
typical class 1 or class 2 domains. For instance, we have not been able
to predict the recognition specificity of the Abp1-SH3 domain by using
the SPOT algorithm (48) or even recognize that its preferred
ligand has an atypical sequence. This implies that the peculiarity of
the Abp1-SH3 domain cannot be revealed by simple alignment of the
domain sequences and comparison of the residues that were seen in
contact with the target peptides in the complexes of the known
structure. Indeed, by superimposing the high resolution
three-dimensional structure of Abp1-SH3 with that of other SH3 domains,
like Abl or Scr, it was not immediately apparent why the Abp1 domain
should fail to recognize the typical class 1 or class 2 consensus sequences. The binding surface in the two
hydrophobic pockets that normally host the PXXP motif are
highly comparable (Fig. 5). When the different SH3 domains are
represented as surfaces, colored according to charge (Fig. 6), the only
difference that stands out is the negative charge of Glu-6 in a
position that is occupied by an hydrophobic residue in most SH3
domains. We have shown that this residue, although it does not make
contact with the ligand peptides in the SH3 complexes of known
structure, contributes to the characteristics of the peptide-binding
pockets. In fact, by changing Glu-6 into a Leu, we were able to modify
the recognition specificity of the Abp1-SH3 domain and promote the
recognition of a classical class 1 peptide (Fig. 6C). This
observation provides an important clue to pinpoint those in a multiple
alignment of SH3 domains that are not likely to be good receptors of
typical PXXP peptides.
According to our model, the hydrophobic pockets in Abp1-SH3 do not
represent an optimized receptor for classical PXXP peptides. As a consequence, the interaction energy with a peptide of typical length is below a threshold of physiological relevance (10-100 µM). To make up for the extra energy, the natural ligands
of Abp1-SH3 would extend their contacts beyond the typical SH3-binding
surface. Our site-directed mutagenesis experiments exclude that
the "anomalous" glutamate at position 21 of the Abp1-SH3 domain may
be involved in binding to this extended peptide target.
 |
FOOTNOTES |
*
The work was supported in part by the EU FP4 program
and CNR target project in biotechnology (to L. C.) and the National
Institutes of Health GM42759 and 50399 (to D. G. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1JO8) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
Both authors contributed equally to the work.
Supported by Human Frontier Science Program Fellowship.

To whom correspondence should be addressed. E-mail:
luisa.castagnoli@uniroma2.it.
Published, JBC Papers in Press, October 19, 2001, DOI 10.1074/jbc.M109848200
 |
ABBREVIATIONS |
The abbreviations used are:
Abp, actin-binding
protein;
Ark, actin-regulating kinase;
GST, glutathione
S-transferase;
ELISA, enzyme-linked immunosorbent assay;
PBS, phosphate-buffered saline;
GFP, green fluorescent protein.
 |
REFERENCES |
| 1.
|
Sorkin, A.
(2000)
J. Cell Sci.
113,
4375-4376[Free Full Text]
|
| 2.
|
Tang, H. Y., Xu, J.,
and Cai, M.
(2000)
Mol. Cell. Biol.
20,
12-25[Abstract/Free Full Text]
|
| 3.
|
Qualmann, B.,
Kessels, M. M.,
and Kelly, R. B.
(2000)
J. Cell Biol.
150,
F111-F116
|
| 4.
|
Westphal, R. S.,
Soderling, S. H.,
Alto, N. M.,
Langeberg, L. K.,
and Scott, J. D.
(2000)
EMBO J.
19,
4589-4600[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Balguerie, A.,
Sivadon, P.,
Bonneu, M.,
and Aigle, M.
(1999)
J. Cell Sci.
112,
2529-2537[Abstract]
|
| 6.
|
Wendland, B.,
and Emr, S. D.
(1998)
J. Cell Biol.
141,
71-84[Abstract/Free Full Text]
|
| 7.
|
Wendland, B.,
Steece, K. E.,
and Emr, S. D.
(1999)
EMBO J.
18,
4383-4393[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Sparks, A. B.,
Hoffman, N. G.,
McConnell, S. J.,
Fowlkes, D. M.,
and Kay, B. K.
(1996)
Nature Biotechnol.
14,
741-744[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Kessels, M. M.,
Engqvist-Goldstein, A. E.,
and Drubin, D. G.
(2000)
Mol. Biol. Cell
11,
393-412[Abstract/Free Full Text]
|
| 10.
|
Lappalainen, P.,
Kessels, M. M.,
Cope, M. J.,
and Drubin, D. G.
(1998)
Mol. Biol. Cell
9,
1951-1959[Free Full Text]
|
| 11.
|
Drubin, D. G.,
Miller, K. G.,
and Botstein, D.
(1988)
J. Cell Biol.
107,
2551-2561[Abstract/Free Full Text]
|
| 12.
|
Lila, T.,
and Drubin, D. G.
(1997)
Mol. Biol. Cell
8,
367-385[Abstract]
|
| 13.
|
Cope, M. J.,
Yang, S.,
Shang, C.,
and Drubin, D. G.
(1999)
J. Cell Biol.
144,
1203-1218[Abstract/Free Full Text]
|
| 14.
|
Drubin, D. G.,
Mulholland, J.,
Zhu, Z. M.,
and Botstein, D.
(1990)
Nature
343,
288-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Mayer, B. J.,
and Eck, M. J.
(1995)
Curr. Biol.
5,
364-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Wu, X.,
Knudsen, B.,
Feller, S. M.,
Zheng, J.,
Sali, A.,
Cowburn, D.,
Hanafusa, H.,
and Kuriyan, J.
(1995)
Structure
3,
215-226[Medline]
[Order article via Infotrieve]
|
| 17.
|
Lim, W. A.,
Richards, F. M.,
and Fox, R. O.
(1994)
Nature
372,
375-379[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Weng, Z.,
Rickles, R. J.,
Feng, S.,
Richard, S.,
Shaw, A. S.,
Schreiber, S. L.,
and Brugge, J. S.
(1995)
Mol. Cell. Biol.
15,
5627-5634[Abstract]
|
| 19.
|
Mongiovi, A. M.,
Romano, P. R.,
Panni, S.,
Mendoza, M.,
Wong, W. T.,
Musacchio, A.,
Cesareni, G.,
and Di Fiore, P. P.
(1999)
EMBO J.
18,
5300-5309[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Kang, H.,
Freund, C.,
Duke-Cohan, J. S.,
Musacchio, A.,
Wagner, G.,
and Rudd, C. E.
(2000)
EMBO J.
19,
2889-2899[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Kato, M.,
Miyazawa, K.,
and Kitamura, N.
(2000)
J. Biol. Chem.
275,
37481-37487[Abstract/Free Full Text]
|
| 22.
|
Felici, F.,
Castagnoli, L.,
Musacchio, A.,
Jappelli, R.,
and Cesareni, G.
(1991)
J. Mol. Biol.
222,
301-310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Cesareni, G.,
Castagnoli, L.,
and Cestra, G.
(1999)
Comb. Chem. High Throughput Screen
2,
1-17[Medline]
[Order article via Infotrieve]
|
| 24.
|
Cestra, G.,
Castagnoli, L.,
Dente, L.,
Minenkova, O.,
Petrelli, A.,
Migone, N.,
Hoffmuller, U.,
Schneider-Mergener, J.,
and Cesareni, G.
(1999)
J. Biol. Chem.
274,
32001-32007[Abstract/Free Full Text]
|
| 25.
|
Paoluzi, S.,
Castagnoli, L.,
Lauro, I.,
Salcini, A. E.,
Coda, L.,
Fre, S.,
Confalonieri, S.,
Pelicci, P. G., Di,
Fiore, P. P.,
and Cesareni, G.
(1998)
EMBO J.
17,
6541-6550[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Yamabhai, M.,
Hoffman, N. G.,
Hardison, N. L.,
McPherson, P. S.,
Castagnoli, L.,
Cesareni, G.,
and Kay, B. K.
(1998)
J. Biol. Chem.
273,
31401-31407[Abstract/Free Full Text]
|
| 27.
|
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
A 276,
307-325
|
| 28.
|
CCP4.
(1994)
Acta Crystallogr. Sec. D
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Navaza, J.
(1994)
Acta Crystallogr. Sec. A
50,
157-163[CrossRef]
|
| 30.
|
Perrakis, A.,
Morris, R.,
and Lamzin, V. S.
(1999)
Nat. Struct. Biol.
6,
458-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Murshudov, G. N.,
Vagin, A. A.,
Lebedev, A.,
Wilson, K. S.,
and Dodson, E. J.
(1999)
Acta Crystallogr. Sec. D
55,
247-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Kleywegt, G. J.,
and Brunger, A. T.
(1996)
Structure
4,
897-904[Medline]
[Order article via Infotrieve]
|
| 33.
|
Laskowski, R. A.,
MacArthur, M. W.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Appl. Crystallogr.
26,
283-291[CrossRef]
|
| 34.
|
Zucconi, A.,
Dente, L.,
Santonico, E.,
Castagnoli, L.,
and Cesareni, G.
(2001)
J. Mol. Biol.
307,
1329-1339[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
| Tong, A. H. Y., Drees, B., Nardelli, G., Bader, G.,
Castagnoli, L., Evangelista, M., Ferracuti, S., Nelson, B., Paoluzi,
S., Quondam, M., Zucconi, A., Hogue, C., Fields, S., Boone, C., and
Cesareni, G. (2001) Science, in press
|
| 36.
|
Guo, S.,
Stolz, L. E.,
Lemrow, S. M.,
and York, J. D.
(1999)
J. Biol. Chem.
274,
12990-12995[Abstract/Free Full Text]
|
| 37.
|
Sparks, A. B.,
Rider, J. E.,
Hoffman, N. G.,
Fowlkes, D. M.,
Quillam, L. A.,
and Kay, B. K.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1540-1544[Abstract/Free Full Text]
|
| 38.
|
Freeman, N. L.,
Lila, T.,
Mintzer, K. A.,
Chen, Z.,
Pahk, A. J.,
Ren, R.,
Drubin, D. G.,
and Field, J.
(1996)
Mol. Cell. Biol.
16,
548-556[Abstract]
|
| 39.
|
Uetz, P.,
Giot, L.,
Cagney, G.,
Mansfield, T. A.,
Judson, R. S.,
Knight, J. R.,
Lockshon, D.,
Narayan, V.,
Srinivasan, M.,
Pochart, P.,
Qureshi-Emili, A., Li, Y.,
Godwin, B.,
Conover, D.,
Kalbfleisch, T.,
Vijayadamodar, G.,
Yang, M.,
Johnston, M.,
Fields, S.,
and Rothberg, J. M.
(2000)
Nature
403,
623-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Ito, T.,
Tashiro, K.,
Muta, S.,
Ozawa, R.,
Chiba, T.,
Nishizawa, M.,
Yamamoto, K.,
Kuhara, S.,
and Sakaki, Y.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1143-1147[Abstract/Free Full Text]
|
| 41.
|
Zeng, G.,
and Cai, M.
(1999)
J. Cell Biol.
144,
71-82[Abstract/Free Full Text]
|
| 42.
|
Benedetti, H.,
Raths, S.,
Crausaz, F.,
and Riezman, H.
(1994)
Mol. Biol. Cell
5,
1023-1037[Abstract]
|
| 43.
|
Ooms, L. M.,
McColl, B. K.,
Wiradjaja, F.,
Wijayaratnam, A. P.,
Gleeson, P.,
Gething, M. J.,
Sambrook, J.,
and Mitchell, C. A.
(2000)
Mol. Cell. Biol.
20,
9376-9390[Abstract/Free Full Text]
|
| 44.
|
Evangelista, M.,
Klebl, B. M.,
Tong, A. H.,
Webb, B. A.,
Leeuw, T.,
Leberer, E.,
Whiteway, M.,
Thomas, D. Y.,
and Boone, C.
(2000)
J. Cell Biol.
148,
353-362[Abstract/Free Full Text]
|
| 45.
|
Weed, S. A.,
Karginov, A. V.,
Schafer, D. A.,
Weaver, A. M.,
Kinley, A. W.,
Cooper, J. A.,
and Parsons, J. T.
(2000)
J. Cell Biol.
151,
29-40[Abstract/Free Full Text]
|
| 46.
|
Goode, B. L.,
Rodal, A. A.,
Barnes, G.,
and Drubin, D. G.
(2001)
J. Cell Biol.
153,
627-634[Abstract/Free Full Text]
|
| 47.
|
Simpson, F.,
Hussain, N. K.,
Qualmann, B.,
Kelly, R. B.,
Kay, B. K.,
McPherson, P. S.,
and Schmid, S. L.
(1999)
Nat. Cell Biol.
1,
119-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Brannetti, B.,
Via, A.,
Cestra, G.,
Cesareni, G.,
and Citterich, M. H.
(2000)
J. Mol. Biol.
298,
313-328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
| 50.
|
Nicholls, A.,
Sharp, K. A.,
and Honig, B.
(1991)
Proteins
11,
281-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Holtzman, D. A.,
Yang, S.,
and Drubin, D. G.
(1993)
J. Cell. Biol.
122,
635-644[Abstract/Free Full Text]
|